Company intelligence / Profile preview

Merit Medical Systems

South Jordan, Utah, United Statesmerit.com ↗

Ownership: Public · MMSI
Employees: ~7000
Development stage: Commercial

Overview

Merit Medical Systems has a broad commercial portfolio of proprietary disposable medical devices used in interventional and diagnostic procedures. The company continues to launch new products and expand its offerings through acquisitions and internal R&D. Recent regulatory milestones include FDA premarket approval for the WRAPSODY Cell-Impenetrable Endoprosthesis in 2024[8].

Therapeutic areas: GastroenterologyCardiovascularNephrologyOtherOncologyNeurology
Modalities: Device
Industry: Surgical Medical Devices

Financials

Market cap: $5.2B
Total revenue: $418.8M
Enterprise value: $5.6B

Beyond the preview

Go deeper on Merit Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merit Medical Systems.

Explore the full profile